supplementary tables from Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential

supplementary tables: Supplemental Table 1. Expression rates of immunohistochemical staining of NDRG2 versus p-Akt or p-PTEN in tumors from OSCC patients. Supplementary table related to Figure 1; Supplemental Table 2. Incidence of tumour formation in the tongue of Ndrg2-deficient mice treated with 4-NQO for 16 weeks. Supplementary table related to Figure 2; Supplemental Table 3. Frequency of SCC (squamous cell carcinoma) tumour formation in the tongue of Ndrg2-deficient mice treated with 4-NQO for 16 weeks. Supplementary table related to Figure 2; Supplemental Table 4. Incidence of tumour formation in wild type and Ndrg2-deficient mice after treatment with 4-NQO for 30 weeks. Supplementary table related to Figure 3; Supplemental Table 5. Incidence of tumour development in wild-type and Ndrg2-deficient mice treated with 4-NQO for 30 weeks. Supplementary table related to Figure 3; Supplemental Table 6. Comparison of the frequency of cervical lymph node metastasis between wild-type control and Ndrg2-deficient mice. Supplementary table related to Figure 3.